Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chattem Exiting Ephedra Market With Dexatrim Reformulations

This article was originally published in The Tan Sheet

Executive Summary

Chattem is getting out of the ephedra business and is set to ship three reformulated Dexatrim SKUs by the end of September
Advertisement

Related Content

Health & Nutrition Systems
Chattem Gold Bond Bolstered With Three New Products Shipping In 2003
Chattem Q3 predictions
Ephedra Product Liability Coverage Now Offered By Fewer Than 10 Insurers
Ephedra Product Liability Coverage Now Offered By Fewer Than 10 Insurers
Metabolife Federal Probe Spurs Release Of Ephedrine Complaint Records
Westchester County Prohibits “Conspicuous” Ephedra Store Displays
Ephedra “Imminent Hazard” Declaration Sought By Sen. Durbin
Ephedra “Imminent Hazard” Declaration Sought By Sen. Durbin
Business & Financial News In Brief

Topics

Advertisement
UsernamePublicRestriction

Register

PS094499

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel